top of page
Search


What Is an Active Pharmaceutical Ingredient (API)?
The Active Pharmaceutical Ingredient (API) is the part of any drug that produces the intended effects. Some drugs, such as combination...
By Kathlyn Stone (journalist and former health
2 min read


The Drug Naming Process
Drugs often have several names. A marketed drug may have up to four different types of names: a chemical name, a company name, a generic...
Kamini Anbil, The Confluence Elite Group, LLC.
4 min read


The twists and turns of naming diseases
When a new disease is identified in a group of patients it needs a name so it can be described, researched and treated. But, unlike...
By Lizzie Crouch BBC Health Check
4 min read


Branding: When One is Not Enough
Launching a second brand is a marketing strategy to address an unmet need distinct from the current brand. In the pharmaceutical industry...
By Ram Subramanian
7 min read


Liposomal medicine names to be changed to avoid errors
The EMA has requested that liposomal medication names be changed to avoid the risk of confusion. All marketing authorisation holders of...
By Rachael Harper (European Pharmaceutical Review)
2 min read


The difference between pharmaceutical and biotechnology
While sitting in a meeting recently I was asked, 'what exactly is the difference between pharma and biopharma?' For most of us, we may...
Michelle Ahern | senior consultant morganmckinley
2 min read


Biosimilar names may affect pharmacist dispensing habits
How biosimilars are named could influence the willingness of pharmacists to substitute such drugs for more expensive biologics, a survey...
by Ed Silverman on DrugPatentWatch.com Posted with
3 min read


Branders give products an identity
In the world of branding, there's a language all its own: Casodex, Grazax, Latisse, Symbicort and Vusion. Each one of those words is the...
By Jenny Staletovich | The Miami Herald
5 min read


The top 10 drugs of 2024
EvaluatePharma analysts predict AbbVie's Humira will top pharma's sales charts in 2024, followed by Merck's Keytruda and Celgene's...
by Eric Sagonowsky | Fiecepharma.com
2 min read


FDA Draft Guidance Requiring Distinct Naming for Biosimilars
Biosimilar Naming Policy Will Help Ensure Patient Safety and Transparency ATLANTA – The American College of Rheumatology (ACR) today...
selected & edited by #pharmanaming.com
1 min read


A drug by any other name would work just as well — making sense of drug names
How are drugs named, and how do names aid in prescription and generic substitution? In William Shakespeare's play Romeo and Juliet,...
reprinted on DrugPatentWatch.com from the book
2 min read


FDA Approves First Sensor Pill to Alert Doctors When It’s Ingested
The U.S. Food and Drug Administration (Silver Spring, MD) has approved a pill that includes a sensor that digitally tracks if patients...
Via: NY Times
3 min read


Can you teach old drugs new tricks?
Faced with skyrocketing costs for developing new drugs, researchers are looking at ways to repurpose older ones — and even some that...
Nicola Nosengo in Nature / 534, 314–316
9 min read


'Accelerated approval' drugs: How well are they studied?
When an investigational prescription drug shows promise for treating a serious illness or filling an unmet medical need, the Food and...
Naci H, Smalley KR
2 min read


The FDA just approved the first direct competitor to a billion-dollar cancer drug
As it stands right now, biosimilars can't be used interchangeably with branded versions, meaning if you were to get a prescription for a...
Lydia Ramsey on uk.BusinessInsider.com
2 min read


Role of brand is 57% more likely to influence a recommendation compared to two years ago
A new report conducted by health branding agency InterbrandHealth measures the value that brands alone provide pharmaceutical companies....
Zach Brooke in Marketing News Weekly
2 min read


What’s in a name? Billions of dollars in tech costs for biosimilars
A new US FDA guidance on how biological products licensed under the Public Health Service Act (PHS Act) need to be named is playing havoc...
PharmaCompass and Ed Silverman on
5 min read


How drug development is speeding up in the cloud
Developing a drug from a promising molecule to a potential life-saver can take more than a decade and cost billions of dollars. Speeding...
By Matthew Wall BBC Technology of Business editor
4 min read


Globalization in the pharmaceutical industry
Where are drugs invented, and how can easily innovation be seeded in new areas? This is the first of DrugPatentWatch's publications...
from www.Drugpatentwatch.com / Copyright 2002-2017
2 min read


Why Biosimilar Drug Names Contain Unhelpful Gibberish
Have you ever wondered how drugs are named? Is there ever a discernible meaning behind drug names? Who manages this mess anyway–drug...
David Kroll on www.forbes.com
4 min read
bottom of page